Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Dermatol ; 58(6): 672-678, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30615189

RESUMO

BACKGROUND: Treatment of psoriatic nail disease is challenging, and dystrophic psoriatic nails can get secondarily infected with fungi. METHODS: This 2-year, matched case-control study was conducted at three tertiary care centers of Karachi, Pakistan. Data were collected from patients with nail psoriasis as cases with age- and gender-matched controls. A detailed questionnaire was filled for all study participants. Nail Psoriasis Severity Index (NAPSI) scoring tool was used to assess dystrophy. Fungal infection was inferred by nail clippings for fungal hyphae and culture. RESULTS: Among 477 participants, 159 cases and 318 controls completed the study. Their mean age was 44 years, and one-third were female. Fungal culture positivity was statistically significant in cases as compared to the control group (P < 0.001). The most frequent species identified was Candida parapsilosis in both cases and controls. Body mass index, NAPSI scoring, socioeconomic status, elevated diastolic blood pressure, smoking status psoriasis among first-degree relatives, and longstanding disease of more than 10 years were significant factors in univariable analysis. Multivariable logistic regression identified independent factors like low to middle socioeconomic status, history of psoriasis in first-degree relative, current smoker, and obesity. CONCLUSION: We found nearly one-third of the psoriatic patients with nail involvement having concomitant fungal infection. We emphasize that nail clipping for fungal smear and culture should be advised to those patients with coexisting factors found significant in our study results. This opinion can be incorporated in psoriasis management guidelines for improving treatment of psoriatic nails.


Assuntos
Candida parapsilosis/isolamento & purificação , Dermatoses do Pé/epidemiologia , Dermatoses da Mão/epidemiologia , Onicomicose/epidemiologia , Psoríase/complicações , Adolescente , Adulto , Estudos de Casos e Controles , Criança , Pré-Escolar , Feminino , Dermatoses do Pé/imunologia , Dermatoses do Pé/microbiologia , Dermatoses da Mão/imunologia , Dermatoses da Mão/microbiologia , Humanos , Masculino , Pessoa de Meia-Idade , Onicomicose/imunologia , Onicomicose/microbiologia , Paquistão/epidemiologia , Prevalência , Psoríase/imunologia , Índice de Gravidade de Doença , Adulto Jovem
2.
Trop Doct ; 42(2): 120-1, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22337728

RESUMO

Cutaneous leishmaniasis is a protozoan disease caused by Leishmania and transmitted by the bite of some species of sand flies. Usually it presents with variety of clinical manifestations depending on both the infecting species of Leishmania and the immune response of the host. Leishmaniasis recidivans cutis (LRC) is a unique form of cutaneous leishmaniasis characterized by unusual clinical features and its chronic relapsing nature. It is an evolving form of cutaneous leishmaniasis which clinically presents as a spreading of the initial nodule, leading to a plaque formation simulating discoid lupus erythematosus. A clinical course of leishmania recidivans is probably related to changes in cell-mediated immunity leading to localized or diffuse lesions. We report a case that presented with infiltrated, atrophic plaque on a patient's face. Clinically, the lesion resembled the lesion of discoid lupus erythematosus and lupus vulgaris but the cutaneous biopsy proved the diagnosis to be LRC.


Assuntos
Dermatoses Faciais/diagnóstico , Dermatoses Faciais/patologia , Leishmaniose Cutânea/diagnóstico , Leishmaniose Cutânea/patologia , Lúpus Eritematoso Discoide/diagnóstico , Lúpus Vulgar/diagnóstico , Antiprotozoários/uso terapêutico , Criança , Diagnóstico Diferencial , Dermatoses Faciais/tratamento farmacológico , Dermatoses Faciais/parasitologia , Humanos , Leishmania/genética , Leishmania/isolamento & purificação , Leishmaniose Cutânea/tratamento farmacológico , Leishmaniose Cutânea/parasitologia , Masculino , Meglumina/uso terapêutico , Antimoniato de Meglumina , Compostos Organometálicos/uso terapêutico , Reação em Cadeia da Polimerase , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA